Physician profile
Matthew E Sendker
NPI 1629031778
$3,338.40
in general payments reported to CMS, 2019-2025
17 companies · $590 in 2025
The $590 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $476 · 2020: $267 · 2021: $333 · 2022: $624 · 2023: $798 · 2024: $251 · 2025: $590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,639.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $790.05 | 2019-2025 | Precision 1, Clareon Panoptix Pro, Total30 |
| Bausch & Lomb Americas INC. | $478.06 | 2022-2025 | Infuse, Miebo, Xiidra |
| Johnson & Johnson Vision Care, INC. | $324.51 | 2019-2025 | Acuvue |
| Sight Sciences, INC. | $300.37 | 2020-2023 | Omni Surgical System, Tearcare System |
| Sun Pharmaceutical Industries INC. | $255.24 | 2019-2025 | Cequa, Xelpros |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $224.25 | 2019-2021 | |
| Coopervision INC. | $197.88 | 2022-2023 | Myday Contact Lens |
| Kala Pharmaceuticals, INC. | $163.69 | 2021-2022 | |
| Abbvie INC. | $138.59 | 2022 | |
| Rayner Intraocular Lenses Limited | $124.99 | 2023 | Omidria, Rayone Emv, Rayone Aspheric |
| Harrow Eye, LLC | $121.03 | 2025 | Vevye |
| Allergan, INC. | $115.01 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $42.41 | 2024 | Xdemvy |
| Optos, INC. | $22.26 | 2020 | |
| Maculogix, INC. | $16.66 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14.15 | 2019 | |
| Biotissue Holdings INC. | $9.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Sendker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.